MEROPENEM FOR INJECTION DIN 02536374
Status: Marketed
Holder: JAMP PHARMA CORPORATION
Molecule: MEROPENEM (MEROPENEM TRIHYDRATE)
Available to quote
Health Canada record
| Active ingredient(s) | MEROPENEM (MEROPENEM TRIHYDRATE) 1 G |
|---|---|
| Dosage form | Powder For Solution |
| Route | Intravenous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | J01DH02 MEROPENEM |
| Original market date | 26-Mar-2024 |
| Current status date | 26-Mar-2024 |
| Source | Health Canada DPD |
Establishment licence of the holder
Jamp Pharma Corporation — licence 100590, currently licensed, last inspection rating C (2025-01-13).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing MEROPENEM (MEROPENEM TRIHYDRATE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02462893 | MEROPENEM FOR INJECTION | AURO PHARMA INC | Powder For Solution | MEROPENEM (MEROPENEM TRIHYDRATE) 1 G | Marketed |
| 02378795 | MEROPENEM FOR INJECTION | SANDOZ CANADA INCORPORATED | Powder For Solution | MEROPENEM (MEROPENEM TRIHYDRATE) 1 G | Marketed |
| 02378787 | MEROPENEM FOR INJECTION | SANDOZ CANADA INCORPORATED | Powder For Solution | MEROPENEM (MEROPENEM TRIHYDRATE) 500 MG | Marketed |
| 02536382 | MEROPENEM FOR INJECTION | JAMP PHARMA CORPORATION | Powder For Solution | MEROPENEM (MEROPENEM TRIHYDRATE) 500 MG | Approved |
| 02493349 | MEROPENEM FOR INJECTION | STERIMAX INC | Powder For Solution | MEROPENEM (MEROPENEM TRIHYDRATE) 1 G | Marketed |
| 02462885 | MEROPENEM FOR INJECTION | AURO PHARMA INC | Powder For Solution | MEROPENEM (MEROPENEM TRIHYDRATE) 500 MG | Marketed |
| 02493330 | MEROPENEM FOR INJECTION | STERIMAX INC | Powder For Solution | MEROPENEM (MEROPENEM TRIHYDRATE) 500 MG | Marketed |
| 02528827 | MEROPENEM FOR INJECTION | EUGIA PHARMA INC. | Powder For Solution | MEROPENEM (MEROPENEM TRIHYDRATE) 1 G | Marketed |
| 02528819 | MEROPENEM FOR INJECTION | EUGIA PHARMA INC. | Powder For Solution | MEROPENEM (MEROPENEM TRIHYDRATE) 500 MG | Marketed |
| 02436493 | MEROPENEM FOR INJECTION USP | STERIMAX INC | Powder For Solution | MEROPENEM (MEROPENEM TRIHYDRATE) 500 MG | Approved |
| 02421518 | TARO-MEROPENEM | SUN PHARMA CANADA INC | Powder For Solution | MEROPENEM (MEROPENEM TRIHYDRATE) 500 MG | Marketed |
| 02421526 | TARO-MEROPENEM | SUN PHARMA CANADA INC | Powder For Solution | MEROPENEM (MEROPENEM TRIHYDRATE) 1 G | Marketed |
| 02554151 | VABOMERE | XEDITON PHARMACEUTICALS INC | Powder For Solution | MEROPENEM (MEROPENEM TRIHYDRATE) 1 G; VABORBACTAM 1 G | Marketed |
| 02430509 | MEROPENEM FOR INJECTION SDZ | SANDOZ CANADA INCORPORATED | Powder For Solution | MEROPENEM (MEROPENEM TRIHYDRATE) 1 G | Cancelled Pre Market |
| 02430495 | MEROPENEM FOR INJECTION SDZ | SANDOZ CANADA INCORPORATED | Powder For Solution | MEROPENEM (MEROPENEM TRIHYDRATE) 500 MG | Cancelled Pre Market |
| 02436507 | MEROPENEM FOR INJECTION USP | STERIMAX INC | Powder For Solution | MEROPENEM (MEROPENEM TRIHYDRATE) 1 G | Dormant |
| 02413787 | MEROPENEM FOR INJECTION USP | PFIZER CANADA ULC | Powder For Solution | MEROPENEM (MEROPENEM TRIHYDRATE) 1 G | Cancelled Pre Market |
| 02413779 | MEROPENEM FOR INJECTION USP | PFIZER CANADA ULC | Powder For Solution | MEROPENEM (MEROPENEM TRIHYDRATE) 500 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 30359 | 2023-03-21 | Abbreviated New Drug Submission (ANDS) |